Targeting a Chemo-Induced Adaptive Signaling Circuit Confers Therapeutic Vulnerabilities in Pancreatic Cancer

Investigators reported a previously unknown chemo-induced symbiotic signaling circuit that adaptively conferred chemoresistance in patients and mice with advanced PDAC.